# Boston Scientific Corporation (BSX) — Q4-2022 Earnings Results

**Report date:** 2023-02-01 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2022

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Up 2.79%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.45 | N/A | -4.46% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management remains focused on strategic initiatives to drive future growth. They acknowledged some headwinds but emphasized their commitment to innovation.

**Key quotes:**

> Management highlighted ongoing investments in innovation and product development.

> They expressed confidence in long-term growth despite current challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a slight miss on EPS, which may raise concerns among some investors. However, the stock reacted positively, increasing by 2.79%, likely due to management's focus on long-term growth and innovation. The absence of guidance may leave some investors uncertain about future performance, but the overall tone from management was cautiously optimistic.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2022_